In 1986,Dimaline et al. 3 )elucidated the structure of a novel 36-residue peptide isolated from chicken antrum.This peptide shares the common C-terminal tetrapeptide amide unit, Trp-Met-Asp-Phe-NH2,with mammalian gastrin4)and cholecystokinin(CCK)51 and was reported to be a potent stimulant of avian gastric acid secretion,but not pancreatic secretion. In order to examine its biological effects on the mammalian digestive tract,we undertook the synthesis of this avian gastrin and CCK family-peptide in two ways,by the solution-phase method and by the solid-phase method.In the latter case,our newly introduced amide precursor reagent6)was employed.
First,we wish to report the solution-phase synthesis of a 36-residue peptide corresponding to the entire amino acid sequence of chicken antral peptide(cAP).Seven peptide fragments were selected as the building blocks to construct its entire peptide backbone as shown in Fig.1 and amino acid derivatives bearing protecting groups removable by treatment with 1 M TMSOTf-thioanisole/TFA7) were employed,i.e., Glu(OBzl),Lys(Z), Arg(Mts),8) Tyr(C12-Bzl),91 Trp(Mts), 10) cedure,and Boc-Tyr-(C12-Bzl)-OH by the DCC plus HOBt procedure,18)successively.The purity of the protected heptapeptide amide thus obtained was ascertained by thin layer chromatography(TLC)and amino acid analysis,after 4 M methanesulfonic acid(MSA)19)or 6 N HCl hydrolysis,as was done with other fragments.
Fragment [2] ,Z(OMe)-Leu-His(Bom)-Asp(OChp)-His(Bom)-Phe-NH2,was prepared with the aid of a substituted hydrazine,Troc-NH-NH2,20)as shown in Fig.3 .First,BocAsp(OChp)-His(Bom)-Phe-NHNH-Troc was prepared in a stepwise manner.A TFAtreated sample of Z(OMe)-Phe-NHNH-Troc21 was condensed with Boc-His(Bom)-NHNH2 by the azide procedure,22)then with Boc-Asp(OChp)-OH via the Su ester.Next, Z(OMe)-Leu-His(Bom)NHNH2 was prepared by the Np condensation23)of Z(OMe)-Leu-OH with a TFA-treated sample of Boc-His(Bom)-OMe,followed by the usual hydrazine treatment.Finally,two fragments thus obtained were condensed by the azide procedure,then the Troc group was removed from the resulting pentapeptide derivative by Zn-AcOH treatment24)to give [2] .
Fragment [3] ,Z(OMe)-Asn-Gly-Ala-Val-Glu(OBzl)-Ala-NHNH2,was prepared in a stepwise manner starting with a TFA-treated sample of Z(OMe)-Ala-NHNH-Troc.25)The respective amino acid residues were successively introduced by the active ester procedure,as [13] [14] [15] [16] [17] [18] shown in Fig.4 ,then the Troc group was cleaved from the resulting hexapeptide derivatives by treatment with Cd powder26)in a mixture of AcOH and DMF.In this step,Cd-treatment gave a more homogeneous product than Zn-treatment. Fragment [4] ,Z(OMe)-Lys(Z)-Gly-Phe-Val-Gln-Gly-NHNH2,was prepared by the azide condensation of two components,Z(OMe)-Lys(Z)-Gly-NHNH227)and Z(OMe)-PheVal-Gln-Gly-OMe,followed by the usual hydrazine treatment,as shown in Fig.5 .A known dipeptide,Z(OMe)-Gln-Gly-OMe,28)served as a starting material to prepared the latter component.This dipeptide,after being treated with TFA,was allowed to react with Z(OMe)-Val-OSu,then with Z(OMe)-Phe-ONp.
Initially,we selected Z(OMe)-Phe-Val-Gln-Gly-NHNH2 as one of the fragments. However,treatment of the corresponding tetrapeptide methyl ester with hydrazine hydrate gave a product with poor solubility in DMF,and even in DMSO.Thus,we decided to add the Lys(Z)-Gly unit onto this tetrapeptide unit to improve the solubility.Indeed,in this way,we were able to obtain fragment [4] ,which could be purified by precipitation from DMF with MeOH as usual.
Fragment [5] ,Z(OMe)-Ser-Asp(OChp)-Arg(Mts)-NHNH2 was prepared in a stepwise manner starting with Z(OMe)-Arg(Mts)-NHNH-Troc,29)as shown in Fig.6 .The two residues were introduced by the Su active ester procedure and the azide procedure, respectively.From the resulting tripeptide derivative,the Troc group was cleaved of by ZnAcOH treatment to give [5] ,which could be purified by precipitation from AcOEt with ether.
Fragment [6] ,Z(OMe)-Ala-Glu(OBzl)-Leu-NHNH2,was prepared in a stepwise man- ner by the active ester procedure,starting with a TFA-treated sample of Z(OMe)-Leu-NHNH-Troc.30)The Np and the Su esters were employed to introduce the Glu(OBzl)and the Ala residues,respectively,as shown in Fig.7 .From the resulting tripeptide derivative,the Troc group was cleaved by Zn-treatment to give [6] ,soluble in MeOH and even in AcOEt.
The N-terminal hexapeptide fragment [7] ,Z(OMe)-Phe-Leu-Pro-His(Bom)-Val-Phe-NHNH2,was prepared according to the scheme shown in Fig.8 .First,Boc-His(Bom)-ValPhe-OMe was prepared in a stepwise manner starting with H-Phe-OMe,onto which the amino acid residues were successively condensed by the Su and the azide procedures, respectively.Next,Z(OMe)-Leu-Pro-OH was prepared by the Np method,but an attempt to crystallize this compound was unsuccessful.The above tripeptide ester,after TFA-treatment, was condensed with Z(OMe)-Leu-Pro-OH by DCC in the presence of HOBt.18)Z(OMe)-Leu-Pro-His(Bom)-Val-Phe-OMe was obtained in a satisfactory yield and this,after TFAtreatment,was allowed to react with Z(OMe)-Phe-OSu to give the protected pentapeptide ester,which was converted to [7] by the usual hydrazine treatment.
Seven peptide fragments thus obtained were then assembled successively according to the route illustrated in Fig.1 .The azide procedure was employed extensively to minimize racemization.As a solvent,DMF or DMF-DMSO(1:1)was employed.The fragment condensations from [1] to [5] proceeded as usual,when each acyl component was employed in a slight excess(1.5 to 2eq).However,for condensation of fragment [6] ,the acyl component was used in larger excess(5eq)and the reaction was continued for 72 h in order to bring the reaction to completion.We encountered considerable difficulty in incorporating fragment [7] into the peptide chain,even by the use of a large excess of the acyl component(5 plus 5eq). Even under these conditions,the acyl component was incorporated into the peptide chain to the extent of only 50 to 60%.Previously,we observed similar phenomena in the syntheses of human and ovine corticotropin releasing factors,31)the circular dichroism(CD)spectra of which indicated predominantly a-helical character.32)The Chou-Fasman technique33)predicted such a-helical conformation at the N-terminal portion of cAP (Fig.1,positions 3 to 13).Thus,the possibility can not be excluded that such a conformational feature may be present in the protected form of cAP and this may account more or less for the difficulty in the coupling reaction mentioned above.
An attempt to purify protected cAP by gel-filtration on Sephadex LH-60 was unsuccessful,since the desired compound emerged from the column with the unreacted amino component,as a single peak,when DMF-DMSO was used as an eluant.It is interesting to note that elution with DMF gave two peaks with similar amino acid compositions(both a mixture of protected cAP and the amino component) (Fig.9) .These results suggested that protected cAP and even the amino component have a tendency to aggregate in DMF,but less in DMSO.Thus,we decided to subject crude protected cAP to the deprotection reaction Except for this protected cAP,other protected intermediates were purified by flash silica gel chromatography34)or by gel-filtration on Sephadex LH-20 or LH-60.Throughout this synthesis,Leu was used as a diagnostic amino acid in acid hydrolysis.By comparison of the recovery of Leu with those of newly incorporated amino acis,satisfactory incorporation of each fragment,except fragment [7] ,was ascertained (Table I ).Elemental analysis of relatively large peptides offers little information about their homogeneity.Therefore,this was not done.
In the final step,crude protected cAP was treated with 1M TMSBr-thioanisole/TFA,35) then with 1M TMSOTf-thioanisole/TFA.The former reagent has an ability to reduce Met(O) to Met and to remove most of the protecting groups,except for the Chp group.The latter treatment was performed to ensure complete deprotection,including the Chp group mentioned above.The deprotected peptide was treated with 1N NH4F containing 6M guanidine HC1 at pH 8.0 to reverse any possible shift36)and to ensure complete hydrolysis of the trimethylsilyl moieties and then incubated with 2-mercaptoethanol at pH 6.0 for 12h to ensure complete reduction of Met(O).The treated peptide was purified by gelfiltration on Sephadex G-25 using 1N AcOH as an eluant.The product was purified to homogeneity by high-performance liquid chromatography(HPLC)on a Cosmosil 5-C18 column using gradient elution with acetonitrile in 0.1% TFA.As predicted,two large peaks were detected.After acid hydrolysis,the front peak was found to be the triacontapeptide missing the N-terminal hexapeptide unit of cAP and the product obtained from the latter eluate was found to possess the amino acid ratios predicted by theory.The desired product thus isolated exhibited a sharp single spot on TLC and a single band on disk isoelectrofocusing(Pharmalyte pH3-10).Its purity was further ascertained by enzymatic digestion and its molecular weight was ascertained by fast atom bombardment mass spectrometry(FAB-MS).
The effects of this synthetic avian peptide on mammalian gastrointestinal functions were examined in rats and the results were compared with those in the case of synthetic CCK-8 (sulfated).First,the effects on pancreatic secretion were tested by using the Love-Tachibana Table I, 
